Tumor-conditioned inter-patient registration using planning computed tomography for voxel-based analysis to predict radiation pneumonitis in lung cancer patients.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
240 patients with LA-NSCLC.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Incorporating VBA-derived dose enhanced RP prediction accuracy compared with using MLD. CRRs identified through VBA were robust to the choice of DIR.
[BACKGROUND AND PURPOSE] Deformable image registration (DIR) for voxel-based analysis (VBA) can be challenging in patients with non-small cell lung cancer (NSCLC) due to large variations in tumor size
- p-value p < 0.001
- p-value p = 0.04
APA
Choi CMS, Jiang J, et al. (2026). Tumor-conditioned inter-patient registration using planning computed tomography for voxel-based analysis to predict radiation pneumonitis in lung cancer patients.. Physics and imaging in radiation oncology, 37, 100907. https://doi.org/10.1016/j.phro.2026.100907
MLA
Choi CMS, et al.. "Tumor-conditioned inter-patient registration using planning computed tomography for voxel-based analysis to predict radiation pneumonitis in lung cancer patients.." Physics and imaging in radiation oncology, vol. 37, 2026, pp. 100907.
PMID
41631006 ↗
Abstract 한글 요약
[BACKGROUND AND PURPOSE] Deformable image registration (DIR) for voxel-based analysis (VBA) can be challenging in patients with non-small cell lung cancer (NSCLC) due to large variations in tumor size and location. This study aimed to assess whether a tumor-preserving inter-patient DIR approach improves VBA-based prediction of radiation pneumonitis (RP).
[METHODS AND MATERIALS] Three DIR methods were evaluated: deep learning-based Tumor-Aware Recurrent Registration (TRACER) and Patient-Specific Context and Shape (PACS), trained on a public dataset of 268 locally-advanced (LA) NSCLC patients, and iterative Symmetric Normalization (SyN). All methods were tested on 240 patients with LA-NSCLC. Geometric, dosimetric, and tumor preservation metrics were compared using the Wilcoxon signed-rank test. VBA was conducted with each DIR method to identify cohort-relevant regions (CRRs). Machine learning models incorporating clinical, dosimetric, and CRR dose features were used to predict grade 2 or higher RP.
[RESULTS] TRACER best preserved tumor volume (1.39 %) and organ doses (mean 0.08 Gy) compared with PACS and SyN (p < 0.001). PACS showed higher geometric but worse dose preservation accuracy than TRACER. All DIR-based VBA methods identified the right lung as the CRR associated with RP. TRACER-derived CRR had slightly higher RP predictive performance (AUC 0.78 vs PACS 0.73 vs SyN 0.71), and outperformed the MLD-based ML model (AUC = 0.78 vs 0.69, p = 0.04; specificity = 0.62 vs 0.48).
[CONCLUSIONS] TRACER improved registration accuracy, with better tumor volume preservation and reduced OAR dose impact. Incorporating VBA-derived dose enhanced RP prediction accuracy compared with using MLD. CRRs identified through VBA were robust to the choice of DIR.
[METHODS AND MATERIALS] Three DIR methods were evaluated: deep learning-based Tumor-Aware Recurrent Registration (TRACER) and Patient-Specific Context and Shape (PACS), trained on a public dataset of 268 locally-advanced (LA) NSCLC patients, and iterative Symmetric Normalization (SyN). All methods were tested on 240 patients with LA-NSCLC. Geometric, dosimetric, and tumor preservation metrics were compared using the Wilcoxon signed-rank test. VBA was conducted with each DIR method to identify cohort-relevant regions (CRRs). Machine learning models incorporating clinical, dosimetric, and CRR dose features were used to predict grade 2 or higher RP.
[RESULTS] TRACER best preserved tumor volume (1.39 %) and organ doses (mean 0.08 Gy) compared with PACS and SyN (p < 0.001). PACS showed higher geometric but worse dose preservation accuracy than TRACER. All DIR-based VBA methods identified the right lung as the CRR associated with RP. TRACER-derived CRR had slightly higher RP predictive performance (AUC 0.78 vs PACS 0.73 vs SyN 0.71), and outperformed the MLD-based ML model (AUC = 0.78 vs 0.69, p = 0.04; specificity = 0.62 vs 0.48).
[CONCLUSIONS] TRACER improved registration accuracy, with better tumor volume preservation and reduced OAR dose impact. Incorporating VBA-derived dose enhanced RP prediction accuracy compared with using MLD. CRRs identified through VBA were robust to the choice of DIR.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Reforming the delivery of smoking cessation: a distributional cost-effectiveness analysis of providing smoking cessation as part of targeted lung cancer screening.
- A herbal formulation inhibits growth and survival of lung cancer cells through DNA damage and apoptosis - in vitro and in vivo studies.
- Negative trial but positive lesson: reframing immunotherapy resistance from one-size-fits-all to precision strategies.
- Lung Cancer Screening in Adults: State-of-the-Art and Policy Mapping (2025).
- Retrospective dosimetric evaluation of the collapsed cone, AAA, and Acuros XB algorithms for lung cancer Halcyon VMAT plans.
- Metastatic Pancreatic Adenocarcinoma with Germline BLM and Somatic ATM Mutations: A Case Report and Review of DNA Damage Response.